Macrogenics Stock Investor Sentiment
| MGNX Stock | USD 1.48 0.06 3.90% |
Slightly above 51% of MacroGenics' investor base is interested to short. The analysis of the overall investor sentiment regarding MacroGenics suggests that many traders are impartial. MacroGenics' investing sentiment can be driven by a variety of factors including economic data, MacroGenics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 49
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use MacroGenics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward MacroGenics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
MacroGenics Historical Sentiment
Although MacroGenics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding MacroGenics, such as negative comments on social media and news outlets, may cause fear in the market and push MacroGenics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of MacroGenics.
MacroGenics | Build AI portfolio with MacroGenics Stock |
MacroGenics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards MacroGenics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MacroGenics Historical Investor Sentiment
Investor biases related to MacroGenics' public news can be used to forecast risks associated with an investment in MacroGenics. The trend in average sentiment can be used to explain how an investor holding MacroGenics can time the market purely based on public headlines and social activities around MacroGenics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
MacroGenics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for MacroGenics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average MacroGenics news discussions. The higher the estimate score, the more favorable the investor's outlook on MacroGenics.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of MacroGenics' Stock prices. Below is the latest headlines and news related to MacroGenics Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about MacroGenics that are available to investors today. This information is accessible both publicly - through MacroGenics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of MacroGenics-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of MacroGenics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MacroGenics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MacroGenics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MacroGenics alpha.
MacroGenics Largest EPS Surprises
Earnings surprises can significantly impact MacroGenics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2014-05-06 | 2014-03-31 | -0.08 | -0.12 | -0.04 | 50 | ||
2023-03-15 | 2022-12-31 | 0.1 | 0.21 | 0.11 | 110 | ||
2020-05-05 | 2020-03-31 | -1.02 | -0.91 | 0.11 | 10 | ||
2017-05-03 | 2017-03-31 | -0.97 | -1.08 | -0.11 | 11 | ||
2017-02-28 | 2016-12-31 | -0.89 | -1.0 | -0.11 | 12 | ||
2019-05-01 | 2019-03-31 | -0.86 | -0.99 | -0.13 | 15 |
There is far too much social signal, news, headlines, and media speculation about MacroGenics that are available to investors today. This information is accessible both publicly - through MacroGenics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of MacroGenics-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of MacroGenics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MacroGenics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MacroGenics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MacroGenics alpha.
MacroGenics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | MacroGenics Announces Date of First Quarter 2025 Financial Results MGNX Stock News | 05/06/2025 |
2 | MacroGenics Price Target Lowered by Stifel MGNX Stock News | 05/14/2025 |
3 | Earnings Release Heres Why Analysts Cut Their MacroGenics, Inc. Price Target To US4.50 | 05/16/2025 |
4 | MacroGenics Sees Target Price Cut Amid Pipeline Focus MGNX Stock News | 05/20/2025 |
5 | Analyst Forecasts For MacroGenics, Inc. Are Surging Higher | 05/21/2025 |
6 | MacroGenics SWOT analysis biotech firms stock faces pipeline challenges By Investing.com - Investing.com India | 05/27/2025 |
7 | Disposition of 13332 shares by Jeffrey Peters of MacroGenics subject to Rule 16b-3 | 05/30/2025 |
8 | MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | 06/03/2025 |
9 | MacroGenics, Sagard Healthcare enter into ZYNYZ royalty purchase MGNX | 06/10/2025 |
10 | MacroGenics Downgraded by Wall Street Zen to Sell | 06/30/2025 |
Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.